ArticleBMC microbiology2026
The TPR family protein VPA1365 regulates biofilm matrix to promote biofilm formation in Vibrio parahaemolyticus.
Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Vibrio parahaemolyticus is a notorious foodborne opportunistic pathogen capable of sensing external environmental signals to regulate its survival and virulence. In recent years, this pathogen has been increasingly detected in freshwater foods, indicating a distribution shift from its original marine reservoirs. Biofilm formation plays a crucial role in its adaptation ability from high-salt to low-salt environments. Here, we showed that VPA1365, a TPR family regulator, significantly promotes biofilm formation in V. parahaemolyticus. The Δvpa1365 mutant exhibited impaired biofilm formation under either low-salt (0.1 M NaCl) or high-salt (0.5 M NaCl) condition compared to that of the wild-type (WT) strain. The deletion of vpa1365 did not alter the flagella-mediated motility, however, it significantly reduced the metabolic activity of biofilm cells and production of key biofilm matrix components (exopolysaccharides, extracellular DNA, and extracellular proteins). Besides, the Δvpa1365 mutant exhibited lower expression levels of biofilm-related genes than that of the WT strain. All observed phenotypes were largely restored to WT levels in the complemented strain Δvpa1365-vpa1365. Therefore, our findings identify VPA1365 as a key regulator that enhances bacterial fitness via the positive regulation of biofilm formation. These insights deeply advance our comprehension of its environmental survival mechanisms and lay the groundwork for interventions to inhibit biofilm formation in V. parahaemolyticus.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.